The Laboratory of Virology and Chemotherapy of the Katholieke Universiteit Leuven focusses on the development of novel antiviral strategies against a number of RNA viruses including (but not limited to) HCV, flaviviruses (mainly dengue) and picornaviruses (rhinovirus inhibitors for the prevention and treatment of exacerbations of asthma and COPD by these viruses). As partner of the EU FP7 funded project SILVER (Small-molecule Inhibitor Leads Versus Emerging and Neglected Viruses) the laboratory is very active in identifying small molecule inhibitors of yet other (neglected) RNA viruses including rabies (see below). The laboratory was involved in the discovery of the anti-HCV activity of Alisporivir, a compound which was developed to phase III clinical trials at Novartis
Katholieke Universiteit Leuven
02 March 2015
Bookmark the permalink.
- No events
- World leaders join new drive to beat noncommunicable diseasesWHO is announcing today a new high-level commission, comprised of heads of state and ministers, leaders in health and development and entrepreneurs. The group will propose bold and innovative solutions to accelerate prevention and control of the leading killers on the planet – noncommunicable diseases (NCDs) like heart and lung disease, cancers, and diabetes. The […]
- Individualized, supportive care key to positive childbirth experience, says WHOWHO has issued new recommendations to establish global care standards for healthy pregnant women and reduce unnecessary medical interventions. Worldwide, an estimated 140 million births take place every year. Most of these occur without complications for women and their babies. Yet, over the past 20 years, practitioners have increased the use of interventions that were […]
- Statement of the Sixteenth IHR Emergency Committee Regarding the International Spread of Poliovirus14 February 2017 – The sixteenth meeting of the Emergency Committee under the International Health Regulations (2005) (IHR) regarding the international spread of poliovirus was convened by the Director General on 7 February 2018 at WHO headquarters with members, advisers and invited member states attending via teleconference.
- World leaders join new drive to beat noncommunicable diseases